Home » Topics » BioWorld Science

BioWorld Science
RSS

Retrotope begins compassionate use trials of RT-001

June 12, 2018

FDA clears Arcus' INDs for AB-928 and AB-122

June 12, 2018

Arcus Biosciences presents CD73 inhibitors

June 12, 2018

Merck & Co. patents DGAT2 inhibitors

June 12, 2018

NeuroRx completes phase IIb/III feasibility enrollment for NRX-101 in suicidal bipolar depression

June 12, 2018

First-in-human data on FDL-176 in healthy subjects presented

June 12, 2018

EMA grants PRIME designation for Themis' Chikungunya vaccine

June 12, 2018

Merck KGaA reports promising phase II data for tepotinib in advanced HCC

June 12, 2018

Lilly and AstraZeneca discontinue phase III trials of lanabecestat for Alzheimer's disease

June 12, 2018

Phase III data support ibrutinib/rituximab combination in Waldenstrom's macroglobulinemia

June 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...